AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.970

+0.0301.55%

Volume:19.37K

Turnover:37.81K

Market Cap:706.33M

PE:-11.51

High:1.990

Open:1.990

Low:1.940

Close:1.940

52wk High:2.250

52wk Low:1.275

Shares:358.54M

Float Shares:275.05M

Volume Ratio:0.37

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.171

EPS(LYR):-0.115

ROE:-143.12%

ROA:-26.53%

PB:17.39

PE(LYR):-17.20

Loading ...

Overview Company News Filings

Concept

Tech Companies-0.03%

Pharmaceutical Companies+1.57%

Capital Flow

Inflow:

Outflow:

News

Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy

MT Newswires Live

Imricor Medical Systems Nears 'Genuine Commercial Inflection Point' After Two Decades of Platform Development, Jarden Says

MT Newswires Live

Imricor Medical Systems Q2 Loss Narrows, Revenue Down

MT Newswires Live

Imricor Medical Secures Second US Customer, Shares Up 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/IMR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.97,"timestamp":1787618820267,"preClose":1.94,"halted":0,"volume":19370,"delay":0,"changeRate":0.01546391752577321,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":358542497,"eps":-0.17112753678663678,"marketStatus":"Trading","change":0.03,"latestTime":"08-25 10:47:28 AEST","open":1.99,"high":1.99,"low":1.94,"amount":37814,"amplitude":0.025773,"askPrice":1.97,"askSize":466,"bidPrice":1.96,"bidSize":1660,"shortable":3,"etf":0,"ttmEps":-0.17112753678663678,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787637600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":1.94,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.369645,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMR.AU","preClose":1.94,"auctionPrice":1.99,"auctionVolume":415,"auctionTime":1787615960387,"referenceTime":1787567403094,"auction":1,"marketStatus":"盘前竞价","timestamp":1787615960387}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-26.53%","roe":"-143.12%","lyrEps":-0.114559,"volumeRatio":0.369645,"shares":358542497,"dividePrice":0,"high":1.99,"amplitude":0.025773,"preClose":1.94,"low":1.94,"week52Low":1.275,"pbRate":"17.39","psRate":"4210.65","week52High":2.25,"institutionHeld":0,"latestPrice":1.97,"committee":0.561618,"eps":-0.17112753678663678,"divideRate":0,"volume":19370,"delay":0,"ttmEps":-0.17112753678663678,"open":1.99,"prevYearClose":1.53,"prevWeekClose":2.01,"prevMonthClose":1.86,"prevQuarterClose":1.845,"fiveDayClose":2.07,"twentyDayClose":1.95,"sixtyDayClose":1.765,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786320000000,"name":null,"time":"","dateTimestamp":1786284000000,"actualEps":null},{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658918639","title":"Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918639","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918639?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:13","pubTimestamp":1786443206,"startTime":"0","endTime":"0","summary":"Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7007","BK7503","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961945","title":"Imricor Medical Systems Nears 'Genuine Commercial Inflection Point' After Two Decades of Platform Development, Jarden Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961945","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961945?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:50","pubTimestamp":1786423845,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) is nearing a \"genuine commercial inflection point\" as it transforms almost two decades of platform development into a recurring, high-margin revenue stream, Jarden sa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","IMR.AU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658604264","title":"Imricor Medical Systems Q2 Loss Narrows, Revenue Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2658604264","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658604264?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:50","pubTimestamp":1786333848,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems'  second-quarter net loss was $7.4 million, compared with $7.8 million in the prior-year quarter, according to a Monday Australian bourse filing.Revenue for the three months ended June 30 came in at $60,500, compared with $65,200 in the year-ago period, the medical device company said.The company said it is expanding its US commercial team, with additional hires to be added during the September and December quarters to cover new regions of the US.Imricor Medical Systems' shares rose nearly 3% in recent trading on Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7503","IMR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609876","title":"Imricor Medical Secures Second US Customer, Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609876","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658609876?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:34","pubTimestamp":1786325656,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  secured its second customer in the US, with Children's Medical Center, Dallas, in Texas purchasing its NorthStar interventional magnetic resonance  mapping and guidance system, according to a Monday Australian bourse filing.The hospital has an existing Philips magnetic resonance lab, which means no lab construction will be required, and procedures guided with the system can begin following installation. Children's Medical Center Dallas will launch a NorthStar-guided interventional magnetic resonance cardiac catheterization program.Its shares rose 3% in recent trading on Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","IMR.AU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMR.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Tech Companies","id":"package_au_concept_kjg","bkCode":"BK7503","changeRate":-0.000335},{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.015741}]}}